• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home

News & stories

Home

News & stories

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2025

Results

No results found. Please try using different filter option(s).

Press releases
1 Jul 2025

Thailand’s Government Pharmaceutical Organization (GPO) partners with DNDi and Pharco to register an effective and affordable hepatitis C treatment  

Young boy in front of a house in rural village
Publications
27 Jun 2025

2024 DNDi Financial Report

Scientific articles
26 Jun 2025

Validated LC-MS/MS method for quantifying the antiparasitic nitroimidazole DNDI-0690 in preclinical target site PK/PD studies

Biomedical Chromatography
BMJ Innovations logo
In the media
17 Jun 2025

Can the use of AI in the pharmaceutical sector deliver new medicines, not new risks?

BMJ Innovations
In the media
17 Jun 2025

Serum Institute signs MoU with DNDi to develop dengue treatment candidate

Business Standard
In the media
17 Jun 2025

‘Timely’ alliance to develop effective dengue treatment

The Sun
ET Pharma logo
In the media
14 Jun 2025

Serum Institute to conduct Brazilian trials of late-stage dengue candidate with DNDi

ET Pharma
In the media
14 Jun 2025

Serum, DNDi to develop affordable dengue treatment

Hindustan Times
The Hindu logo
In the media
14 Jun 2025

SII, DNDi partner for expanding human trials for dengue treatment

The Hindu
Press Trust of India logo
In the media
13 Jun 2025

Serum, DNDi join hands to fast-track development of new treatment for dengue

Press Trust of India
Emergency room in Vellore, India
Press releases
13 Jun 2025

Serum Institute of India signs a memorandum of understanding (MoU) with DNDi to advance the development of a new treatment for dengue in low- and middle-income countries

Press Releases Translations
13 Jun 2025

DNDi와 소외질환 치료제 개발 공동 연구 나선다

Press releases
13 Jun 2025

K-MEDI and DNDi have initiated collaborative R&D to develop a treatment for neglected diseases

France 24 logo
In the media
10 Jun 2025

Sudanese doctors on mission to rebuild Mycetoma Research Centre

France 24
In the media
8 Jun 2025

Uncovering Turkana’s Silent Plague: The Gruesome Disease Crippling a Region

The Kenyan Historian
TV5Monde-logo
In the media
8 Jun 2025

Kenya: le mycétome, une maladie endémique pourtant encore négligée

TV5Monde
loading

News

Loading...
News
6 Jun 2025

DNDi is partnering with Médecins Sans Frontières South Asia for the Without Borders Media Fellowship 2025 

News
5 Jun 2025

Meet the DNDi Eastern Africa 2024-2025 Media Fellows

News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

see ALL

Stories

Loading...
Fishermen in canoes on the river
Stories
13 May 2025

L’élimination de la maladie du sommeil en Guinée, vue de l’intérieur

Lab activities
Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Stories
14 Apr 2025

DNDi supporting a pioneering project that integrates Indigenous knowledge in the treatment of Chagas

Jadel Kratz, Jadel Müller Kratz, DNDi’s Head of Discovery and R&D Partnerships drawing molecules on a board
Stories
26 Mar 2025

Drug discovery explained: What is lead optimization?

see ALL

Viewpoints

Loading...
Viewpoints
9 Apr 2025

Como acabar de vez com as doenças negligenciadas?

Veja Saúde
Viewpoints
3 Apr 2025

Africa’s greatest health challenges won’t be solved without female scientists

TRT Afrika
Viewpoints
3 Apr 2025

Opinion: How patents can serve the common good

Chemical & Engineering News
Viewpoints
8 Mar 2025

Women are poorly represented in clinical trials. That’s problematic

Nature India
see ALL

Statements

Loading...
Statements
27 May 2025

DNDi interventions at the 78th World Health Assembly

Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Statements
12 Feb 2025

DNDi statement on recent US government executive actions and the escalating retreat from global health and medical research

see ALL

Social media

    Stay connected

    Get our latest news, personal stories, research articles, and job opportunities. 

    Linkedin-in Instagram Twitter Facebook-f Youtube
    International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

    Learn more

    • Diseases
    • Neglected tropical diseases
    • R&D portfolio
    • Policy advocacy

    Get in touch

    • Our offices
    • Contact us
    • Integrity Line

    Support us

    • Donate
    • Subscribe to eNews

    Work with us

    • Join research networks
    • Jobs
    • RFPs
    • Terms of Use   
    •   Acceptable Use Policy   
    •   Privacy Policy   
    •   Cookie Policy   
    •   Our policies   

    • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License